Redicalm
Natural health product licensed in Canada
- Licence holder
- Nutreance
- NPN or DIN-HM
- 80075661
- Status
- Active licence
- Licence date
- 15 February 2017
- Revision date
- 11 April 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Melissa officinalis Source : Feuille et tige | 50 milligramme | Not calculated |
| L-théanine Source : L-Théanine | 100 milligramme | Not calculated |
| Withania somnifera Source : Racine | 50 milligramme | Not calculated |
| L-5-hydroxytryptophane Source : Griffonia simplicifolia, graine | 100 milligramme | Not calculated |
| Passiflora incarnata Source : Sommité | 50 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose, Stéarate de magnésium, farine de riz
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Helps to temporarily promote relaxation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended. Consult a health care practitioner for use beyond one year. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking carbidopa or drugs/supplements with serotonergic activity. These may include, but are not limited to, L-tryptophan, S-adenosylmethionine (SAMe), St. John's wort, antidepressants, pain killers, over the counter cough and cold medication containing dextromethorphan, anti-nausea medication and anti-migraine medication. Discontinue use and consult a health care practitioner if you show signs of weakness, oral ulcers, or abdominal pain accompanied by severe muscle pain or if you experience skin changes. Do not use if you have scleroderma. Hypersensitivity (e.g. allergy) has been known to occur; in which case discontinue use.
Source
Official Health Canada record, licence 80075661
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.